ACHC
Acadia Healthcare Company Inc
28.10$
+4.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 68.2% | 75.9% | 63.6% | 62.5% | 62.1% | 58.8% | 59.0% | 58.2% | 59.0% | 59.4% | 4.2% | 3.9% | 3.8% | 76.7% | 77.4% | 82.4% | |
| 31.8% | 24.1% | 36.4% | 37.5% | 37.9% | 41.2% | 41.0% | 41.8% | 41.0% | 40.6% | 95.8% | 96.1% | 96.2% | 23.3% | 22.6% | 17.6% | |
| – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 5.0% | 26.1% | 6.6% | 6.6% | 6.4% | 8.3% | 9.2% | 9.6% | 10.2% | 5.9% | 62.8% | 61.3% | 61.2% | 6.0% | 6.0% | 5.9% | |
| 17.6% | 37.3% | 19.0% | 20.3% | 20.7% | 23.4% | 25.1% | 26.4% | 27.3% | 7.7% | 95.8% | 78.2% | 78.2% | 6.0% | 6.0% | 5.9% | |
| 14.2% | -13.1% | 17.4% | 17.2% | 17.2% | 17.9% | 15.8% | 15.4% | 13.7% | 32.9% | 17.5% | 17.9% | 17.9% | 17.3% | 16.6% | 11.7% | |
| 1.2% | 4.2% | 7.3% | 5.2% | 4.8% | 5.9% | 6.5% | 6.2% | 6.2% | 9.3% | 7.6% | 3.3% | 2.7% | 2.8% | 3.7% | 4.2% | |
| 11.5% | -17.3% | 8.1% | 9.7% | 12.6% | 9.2% | 1.2% | 8.3% | -5.6% | 3.9% | 8.8% | 11.9% | 14.3% | -0.9% | 10.8% | -32.2% | |
| 0.8% | -2.4% | 3.0% | 3.6% | 4.3% | 2.6% | 1.0% | 1.3% | 0.2% | 1.2% | 1.9% | 2.9% | 3.6% | -0.3% | 2.5% | 0.8% | |
| 10.0% | -15.8% | 5.0% | 6.0% | 8.3% | 6.7% | 0.2% | 7.0% | -5.8% | 5.4% | -32.2% | 8.2% | 10.5% | -0.7% | 8.1% | -33.3% | |
| 14.3% | -11.2% | 17.3% | 19.6% | 20.4% | 21.4% | 20.6% | 20.5% | 12.8% | 20.0% | 20.9% | 19.9% | 21.5% | 6.5% | 19.3% | -22.3% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.